OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
Kausik K. Ray, Carlos Aguíar, Marcello Arca, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 15, pp. 1792-1803
Open Access | Times Cited: 10
Kausik K. Ray, Carlos Aguíar, Marcello Arca, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 15, pp. 1792-1803
Open Access | Times Cited: 10
Showing 10 citing articles:
Therapeutic Inertia in Dyslipidemia Management for Secondary Cardiovascular Prevention: Results from the Italian ITACARE-P Network
Andrea Faggiano, Anna Gualeni, Lucia Barbieri, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 493-493
Open Access | Times Cited: 1
Andrea Faggiano, Anna Gualeni, Lucia Barbieri, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 493-493
Open Access | Times Cited: 1
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database
Antonio Rossi, Davide Masi, Rita Zilich, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Antonio Rossi, Davide Masi, Rita Zilich, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: a French nationwide study
Matthieu Wargny, Thomas Goronflot, Pierre‐Guillaume Piriou, et al.
Diabetes & Metabolism (2025), pp. 101638-101638
Open Access
Matthieu Wargny, Thomas Goronflot, Pierre‐Guillaume Piriou, et al.
Diabetes & Metabolism (2025), pp. 101638-101638
Open Access
Cardiovascular Risk Assessment and Lipid-Lowering Therapy Recommendations in Primary Prevention
Aikaterini Komnianou, Konstantinos G. Kyriakoulis, Ariadni Menti, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2220-2220
Open Access
Aikaterini Komnianou, Konstantinos G. Kyriakoulis, Ariadni Menti, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2220-2220
Open Access
Therapeutic inertia in lipid management among Polish adults with type 1 diabetes - results from the cross-sectional PARADISE T1DM Study
Mikołaj Kamiński, Michał Kulecki, Dominika Kasprzak, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 103853-103853
Open Access
Mikołaj Kamiński, Michał Kulecki, Dominika Kasprzak, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 103853-103853
Open Access
Racing to Normal: A Case Report of Rapid and Notable Cholesterol Reduction With Statin and Ezetimibe Combined Therapy
D. Zucca Aparicio, Marta Costa, Rui Marques
Cureus (2025)
Open Access
D. Zucca Aparicio, Marta Costa, Rui Marques
Cureus (2025)
Open Access
Distribution of lipoprotein (a) levels in patients with lower extremity artery disease and their impact on amputation and survival: a retrospective study
Katrin Gebauer, Nasser Malyar, Julian Varghese, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Katrin Gebauer, Nasser Malyar, Julian Varghese, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
Margrét Leósdóttir, Jessica R. Schubert, Julia Brandts, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 15, pp. 1550-1564
Open Access
Margrét Leósdóttir, Jessica R. Schubert, Julia Brandts, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 15, pp. 1550-1564
Open Access
Reducing the risk of heart attack: the key role of lipid profiling and atherosclerosis imaging
Flavio Giuseppe Biccirè, Franco Mastroianni, Mihail Celeski, et al.
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_3, pp. iii22-iii24
Open Access
Flavio Giuseppe Biccirè, Franco Mastroianni, Mihail Celeski, et al.
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_3, pp. iii22-iii24
Open Access
EJPC @ a glance: focus issue on lipid disorders and cardiovascular prevention
Charles Fauvel, Victor Aboyans
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 15, pp. 1775-1777
Closed Access
Charles Fauvel, Victor Aboyans
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 15, pp. 1775-1777
Closed Access
¿Cómo alcanzar los objetivos en colesterol LDL con los criterios de financiación de los nuevos fármacos hipolipemiantes?
Antón González-Guerrero, Elisenda Climent, David Benaiges, et al.
Clínica e Investigación en Arteriosclerosis (2024), pp. 500752-500752
Closed Access
Antón González-Guerrero, Elisenda Climent, David Benaiges, et al.
Clínica e Investigación en Arteriosclerosis (2024), pp. 500752-500752
Closed Access
Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up study
Mayank Dalakoti, Denis Angoulvant
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 15, pp. 1804-1805
Open Access
Mayank Dalakoti, Denis Angoulvant
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 15, pp. 1804-1805
Open Access
